Skip to main content
SpringerLink
Log in

Proof of principle for the use of 11C-labelled peptides in tumour diagnosis with PET

  • Short Communication
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Purpose

The future significance of peptide radiopharmaceuticals in diagnostic imaging with PET will be dependent on methodological aspects, as well as other requirements such as availability of the radionuclide and cost-effectiveness of its production. The aim of this study was to evaluate whether recent improvements in the modification of peptide pharmacokinetics by carbohydration may open a niche for the use of 11C-labelled peptide receptor binding tracers.

Methods

A carbohydrated analogue of Tyr3-octreotate was used as a clinically relevant peptide. Oxime-mediated coupling between 4-[11C]methoxy-benzaldehyde and an aminooxy-conjugated peptide precursor provided the 11C-labelled peptide in 21±5% decay-corrected yield (n=4) in a synthesis time of about 1 h.

Results

In rat pancreas carcinoma xenografted mice, the compound displayed predominant and fast renal clearance combined with high tumour uptake (18.5±2.8% ID/g) at 30 min post injection. Corresponding values for kidney, liver and intestine were 18.5±2.4% ID/g, 3.2±0.5% ID/g and 2.1±0.3% ID/g, respectively. In a PET study with xenografted mice, the tumour (0.2–0.3 g) was clearly delineated as early as 20 min after injection. Somatostatin receptor (sstr)-specific uptake was demonstrated by reduction of tumour uptake to 20% of control by co-injection of TOC (0.4 mg/kg; 30 min p.i.).

Conclusion

A 11C-labelled octreotate derivative has been prepared which shows suitable pharmacokinetics for in vivo imaging of sstr-overexpressing tumours and thus represents the first proof of principle for the potential of 11C-labelled peptides in tumour imaging.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Henze M, Schuhmacher J, Hipp P, Kowalski J, Becker DW, Doll J, et al. PET imaging of somatostatin receptors using [68Ga]DOTA-d-Phe1-Tyr3-Octreotide: first results in patients with meningiomas. J Nucl Med 2001;42:1053–1056.

    CAS  PubMed  Google Scholar 

  2. Wester H-J, Schottelius M, Scheidhauer K, Meisetschläger G, Herz M, Rau FC, et al. PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide. Eur J Nucl Med Mol Imaging 2003;30:117–122.

    Article  CAS  PubMed  Google Scholar 

  3. Lundqvist H, Tolmachev V. Targeting peptides and positron emission tomography. Biopolymers 2002;66:381–392.

    Article  CAS  PubMed  Google Scholar 

  4. Schottelius M, Wester HJ, Reubi JC, Senekowitsch-Schmidtke R, Schwaiger M. Improvement of pharmacokinetics of radioiodinated Tyr(3)-octreotide by conjugation with carbohydrates. Bioconjug Chem 2002;13:1021–1030.

    Article  CAS  PubMed  Google Scholar 

  5. Wester H-J, Schottelius M, Scheidhauer K, Reubi J-C, Wolf I, Schwaiger M. Comparison of radioiodinated TOC, TOCA and Mtr-TOCA: the effect of carbohydration of pharmacokinetics. Eur J Nucl Med Mol Imaging 2002;29:28–38.

    Article  CAS  PubMed  Google Scholar 

  6. Haubner R, Wester HJ, Burkhart F, Senekowitsch-Schmidtke R, Weber W, Goodman SL, et al. Glycosylated RGD-peptides: tracer for tumor targeting and angiogenesis imaging with improved pharmacokinetics. J Nucl Med 2001;42:326–336.

    CAS  PubMed  Google Scholar 

  7. Hartvig P, Nagren K, Lundberg PO, Muhr C, Terenius L, Lundqvist H, et al. Kinetics of four 11C-labelled enkephalin peptides in the brain, pituitary and plasma of rhesus monkeys. Regul Pept 1986;16:1–13.

    Article  CAS  PubMed  Google Scholar 

  8. Berger G, Mazière M, Prenant C, Sastre J, Comar D. 11C labelling of a protein: concanavalin A. Int J Appl Radiat Isot 1984;35:81–83.

    Article  CAS  PubMed  Google Scholar 

  9. Poethko T, Shottelius M, Thumshirn G, Hersel U, Herz M, Henriksen G, et al. Two-step methodology for high-yield routine radiohalogenation of peptides: 18F-labelled RGD and octreotid analogues. J Nucl Med 2004;45:892–902.

    PubMed  Google Scholar 

  10. Schottelius M, Poethko P, Herz M, Kessler H, Schwaiger M, Wester HJ. First 18F-labelled tracer suitable for routine clinical imaging of sstr-expressing tumors using positron emission tomography. Clin Cancer Res 2004;10:3593–606.

    CAS  PubMed  Google Scholar 

  11. Stabin MG. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996;37:538–546.

    CAS  PubMed  Google Scholar 

  12. Wester HJ, Brockmann J, Rosch F, Wutz W, Herzog H, Smith-Jones P, et al. PET-pharmacokinetics of 18F-octreotide: a comparison with 67Ga-DFO- and 86Y-DTPA-octreotide. Nucl Med Biol 1997;24:275–286.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Nuklearmedizinische Klinik und Poliklinik, Klinikum rechts der Isar, Technische Universität München, Ismaningerstrasse 22, 81675, Munich, Germany

    G. Henriksen, M. Schottelius, T. Poethko, A. Hauser, I. Wolf, M. Schwaiger & Hans-Jürgen Wester

Authors
  1. G. Henriksen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Schottelius
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Poethko
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Hauser
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I. Wolf
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. Schwaiger
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hans-Jürgen Wester
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hans-Jürgen Wester.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Henriksen, G., Schottelius, M., Poethko, T. et al. Proof of principle for the use of 11C-labelled peptides in tumour diagnosis with PET. Eur J Nucl Med Mol Imaging 31, 1653–1657 (2004). https://doi.org/10.1007/s00259-004-1582-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-004-1582-1

Keywords

Search

Navigation